A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy Adults
Clinical trial NCT06392659 · COMPLETED
Trial details
- NCT number
- NCT06392659
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-02
- Primary completion
- 2024-07-02
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.